Showing results (2121-2130 of 2,548) with videos related to

Sort By:
Pageof 255
European Heart Journal. Cardiovascular Imaging|October 11, 2021
Left atrial strain predicts incident atrial fibrillation in the general population: the Copenhagen City Heart StudyRaphael Hauser, Anne Bjerg Nielsen, Kristoffer Grundtvig Skaarup, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 12, 2009
Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary interventionLisette Okkels Jensen, Anne Kaltoft, Per Thayssen, et al.
Molecular Oncology|September 5, 2020
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational studyDorte S Nørøxe, Christina W Yde, Olga Østrup, et al.
NPJ Genomic Medicine|July 3, 2019
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancerBirgitte Bertelsen, Ida Viller Tuxen, Christina Westmose Yde, et al.
Crohn'S & Colitis 360|February 13, 2023
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020Mads Damsgaard Wewer, Laura Arp, Melek Sarikaya, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Dose-dependent cerebrovascular impact of pediatric brain radiotherapy revealed by advanced MRI: the AVARTHEC studyAnne Laprie, Line Claude, Emmanuel Desandes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 9, 2026
Long-Term Outcomes After Percutaneous Coronary Intervention With the Polymer-Free Biolimus-Coated BioFreedom Stent Versus the Biodegradable-Polymer Sirolimus-Eluting Orsiro Stent in Patients With Acute Coronary SyndromesManijeh Noori, Evald Høj Christiansen, Mikkel Hougaard, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2019
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24Mansoor Raza Mirza, Troels K Bergmann, Morten Mau-Sørensen, et al.
Pageof 255